Digitalis toxicity is caused by the cardiac glycoside digoxin, which is commonly used to treat heart conditions but has a narrow therapeutic window. Digoxin toxicity can cause various cardiac arrhythmias by inhibiting the sodium-potassium pump in cardiac cells. Management of digoxin toxicity involves supportive care, treating arrhythmias, correcting electrolyte abnormalities, and administering digoxin antibody fragments for severe cases. Symptoms and signs of digoxin toxicity can affect the heart, gastrointestinal system, central nervous system, and vision.
Digoxin & Nitroglycerin by Dr. Sanaullah Aslam (Complete)Sanaullah Aslam
Your Feedback will be highly appreciated. This presentation was made for students at pharmacy institute in a project of clinical pharmacy and use of digoxin and nitroglycerin. This presentation is made so that you can present it in a same session, without any change.
Digoxin & Nitroglycerin by Dr. Sanaullah Aslam (Complete)Sanaullah Aslam
Your Feedback will be highly appreciated. This presentation was made for students at pharmacy institute in a project of clinical pharmacy and use of digoxin and nitroglycerin. This presentation is made so that you can present it in a same session, without any change.
Digoxin & Nitroglycerin by Dr. Sanaullah AslamSanaullah Aslam
Your Feedback will be highly appreciated. This presentation was made for students at pharmacy institute in a project of clinical pharmacy and use of digoxin and nitroglycerin. This presentation is made so that you can present it in a same session, without any change.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
micro teaching on communication m.sc nursing.pdfAnurag Sharma
Microteaching is a unique model of practice teaching. It is a viable instrument for the. desired change in the teaching behavior or the behavior potential which, in specified types of real. classroom situations, tends to facilitate the achievement of specified types of objectives.
New Drug Discovery and Development .....NEHA GUPTA
The "New Drug Discovery and Development" process involves the identification, design, testing, and manufacturing of novel pharmaceutical compounds with the aim of introducing new and improved treatments for various medical conditions. This comprehensive endeavor encompasses various stages, including target identification, preclinical studies, clinical trials, regulatory approval, and post-market surveillance. It involves multidisciplinary collaboration among scientists, researchers, clinicians, regulatory experts, and pharmaceutical companies to bring innovative therapies to market and address unmet medical needs.
Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMSAkankshaAshtankar
MIP 201T & MPH 202T
ADVANCED BIOPHARMACEUTICS & PHARMACOKINETICS : UNIT 5
APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS By - AKANKSHA ASHTANKAR
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
CDSCO and Phamacovigilance {Regulatory body in India}NEHA GUPTA
The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice.
Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health.
In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...kevinkariuki227
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Verified Chapters 1 - 19, Complete Newest Version.pdf
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
Basavarajeeyam is a Sreshta Sangraha grantha (Compiled book ), written by Neelkanta kotturu Basavaraja Virachita. It contains 25 Prakaranas, First 24 Chapters related to Rogas& 25th to Rasadravyas.
These simplified slides by Dr. Sidra Arshad present an overview of the non-respiratory functions of the respiratory tract.
Learning objectives:
1. Enlist the non-respiratory functions of the respiratory tract
2. Briefly explain how these functions are carried out
3. Discuss the significance of dead space
4. Differentiate between minute ventilation and alveolar ventilation
5. Describe the cough and sneeze reflexes
Study Resources:
1. Chapter 39, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 34, Ganong’s Review of Medical Physiology, 26th edition
3. Chapter 17, Human Physiology by Lauralee Sherwood, 9th edition
4. Non-respiratory functions of the lungs https://academic.oup.com/bjaed/article/13/3/98/278874
2. Introduction
• One of top toxins in the world because of the wide
availability of digoxin and a narrow therapeutic
window.
• Digitalis is a plant-derived cardiac glycoside
commonly used in the treatment of congestive heart
failure (CHF), atrial fibrillation, and reentrant
supraventricular tachycardia.
• Digoxin-specific fragment antigen-binding (Fab)
antibody has contributed significantly to the
improved morbidity and mortality of toxic patients
4. -Normal depolarization of the cardiac myocyte begins
with the opening of the fast sodium channels. The
resulting increase in intracellular sodium, and
subsequent change in the resting membrane
potential, opens voltage-gated calcium channels. The
initial influx of calcium induces further release of
calcium from the sarcoplasmic reticulum, which
results in muscle contraction.
- Sodium is then removed from the cell by, among
several mechanisms, the sodium-potassium ATPase.
Some calcium is removed from the cell by the sodium-
calcium antiporter.
5. Mechanism Of Action
The positive inotropic effect of digitalis has the following
component:
Direct inhibition of membrane-bound Na+/K+ -ATPase,
which normally pumps 3 Na+ outside the cell in exchange
with 2 K+ inside the cell which is responsible for
maintenance of resting membrane potential (RMP) in
most excitable cells.
6. • Increased amounts of Ca2+also leads to increased
storage of calcium in the sarcoplasmic reticulum,
causing a corresponding increase in the release of
calcium during each action potential. This leads to
increased contractility of the heart (inotropic effect).
7. - They exert negative chronotropic effect
through vagal and extravagal stimulation.
- They decrease AV conduction through
direct action on the myocardium and vagal
stimulation.
- They increase heart automaticity in by
shortening the refractory period of atria and
venticles
8.
9. Pathophysiology
1. Cardiac: arrhythmia
• Alterations in cardiac rate and rhythm occurring in
digitalis toxicity may simulate almost every known
type of arrhythmia.
- Decrease AV conduction leading to bradycardia and
heart block (first, second, third).
Indeed, AV junctional block of varying degrees, alone or
with increased ventricular automaticity, are the most
common manifestations of digoxin toxicity, occurring
in 30-40% of patients with recognized digoxin
toxicity.
10. - Increase automaticity leading to several types of
tachyarrhythmias.
When conduction and the normal pacemaker are both
depressed, ectopic pacemakers may take over,
producing atrial and ventricular tachycardia.
2- Arrhythmias can cause inadequate tissue perfusion,
with resultant central nervous system (CNS) and renal
mplications such as the following:
• Hypoxic seizures
• Acute tubular necrosis
11.
12. 3- Hyperkalemia is the major electrolytic complication in
acute, massive digoxin poisoning. In addition
hyperkalmemia slows AV conduction adding to digoxin
toxicity.
Hypokalemia is seen with chronic toxicity.
13. 4- GIT manifestations:
nausea, vomiting, abdominal pain, anorexia
vagal stimulation>>
Chemoreceptor trigger zone
5- Visual disturbance:
colored vision (yellow and green
patches), Scotomata, diplopia.
14. Digoxin pharmacokinetics
• The onset of action by oral administration occurs in
30-120 minutes
• the onset of action with intravenous administration
occurs in 5-30 minutes.
• its bioavailability is 95%.
• Only 1% of the total amount of digoxin in the body is
in the serum; of that amount about 30 % bound to
plasma proteins.
• Large volume of distribution about 8L.
15. • The kidney excretes 60-80% of the digoxin dose
unchanged.
• A dose less than 5 mg is rarely to cause toxicity,
however a dose higher than 11 mg may be fatal
• In pediatrics a dose higher than 4 mg can cause
toxicity.
• Because of digoxin's large volume of distribution and
molecular weight, extracorporeal removal is not
beneficial. Neither hemoperfusion nor hemodialysis
have been shown to be helpful in the management of
digoxin toxicity.
16. CLINICAL FEATURES AND DIAGNOSIS of toxicity:
History:
-Determine the agent, amount taken, time of
ingestion, and any coingestants whenever possible.
- Determine also if the patient normally takes digitalis
or if it was someone else's prescription.
- Ask about symptoms suggesting an acute illness.
- Inquire carefully about gastrointestinal, cardiac, and
neurologic manifestations, including visual
disturbances.
- Inquire also about symptoms that suggest
hypoperfusion, such as confusion and abdominal
pain, which may stem from mesenteric ischemia.
17.
18. Circumstances of toxicity
• Deteriorating renal function, dehydration, electrolyte
disturbances, or drug interactions usually precipitate
chronic toxicity.
• Acute overdose or accidental exposure to plants containing
cardiac glycosides may cause acute toxicity.
• Acute, non therapeutic overdose—unintentional, suicidal,
or homicidal—can cause toxicity
19. LABORATORY AND ECG EVALUATION:
(1) Serum digoxin concentration:
With acute toxicity, ideally, blood samples should be
collected four hours after an intravenous dose or six
hours after an oral dose in order to account for drug
distribution and obtain an accurate measurement.
20. (2) Serum potassium concentration:
-Hyperkalemia is correlated with mortality in acute intoxication.
- All patients with an initial potassium level greater than 5.5 have poor
prognosis.
-As regards chronic toxicity, the most common precipitating cause of
digitalis intoxication is hypokalemia which occurs often in patients with
heart failure as a result of diuretic therapy.
(3) Creatinine and BUN to assess renal function:
Renal dysfunction is also commonly encountered in the setting of
chronic digoxin toxicity and is often what precipitates the rise in the
digoxin level.
(4) Serial electrocardiograms:
24. Managment
• A- B - C
• hydration with IV fluids, oxygenation and support of
ventilatory function, discontinuation of the drug,
and, sometimes, the correction of electrolyte
imbalances.
• Fab antibody fragments are extremely effective in
the treatment of severe, acute digitalis toxicity
25. GI Decontamination and Enhanced
Elimination
• The administration of activated charcoal (AC)
or cholestyramine for gastrointestinal decontamination
should be viewed as adjunctive and not primary therapy in
patients with digitalis poisoning.
• Patients suspected of having an acute digitalis intoxication
who present to the emergency department within one to
two hours of ingestion may benefit from the administration
of AC.
• Cardiac glycosides undergo some degree of enterohepatic
or enteroenteric recirculation and are adsorbed
to activated charcoal . AC or multi-dose AC (MDAC) are
recommended for digitalis toxicity .
26. • Management of arrhythmia:
- In case of tachycardia: give lidocaine or phenytoin
(No effect on AV conduction).
- Life-threatening ventricular arrhythmias are treated
according to the algorithms of advanced cardiac life
support (ACLS).
- In case of bradycardia: give atropine.
- Correct electrolyte disturbances
- In case of hyperkalemia: give EDTA and give insulin +
glucose to shift K+ intracellularly But Ca gluconate is
contraindicated
• However, hyperkalemia itself does not cause death, and
treatment with potassium-lowering agents
does not reduce mortality.
27.
28. Indications of Antidotal therapy with antibody (Fab) fragments
- Fab fragments should be given in all cases of severe
digitalis poisoning.
- Life-threatening arrhythmia (eg, ventricular tachycardia;
ventricular fibrillation; asystole; complete heart block;
Mobitz II heart block; symptomatic bradycardia)
-Evidence of end-organ dysfunction (eg, renal failure,
altered mental status)
-Hyperkalemia (serum potassium >5 to 5.5 meq/L)
-serum digoxin concentration is greater than
10 ng/mL at steady state in acute ingestions, or greater
than 4 ng/mL in chronic ingestions
- an adult ingests more than 10 mg or a child more than 4
mg acutely.